Catalent Inc
Company Profile
Business description
Catalent is a contract development and manufacturing organization, or CDMO. It operates under four segments: biologics, softgel and oral technologies, oral and specialty delivery, and clinical supply services. Catalent derives its revenues primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products throughout the entire life cycle of a product from the drug development process to commercial supply. Catalent has over 50 facilities across four continents.
Contact
14 Schoolhouse Road
SomersetNJ08873
USAT: +1 732 537-6200
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
30 June 2025
Employees
16,900
Catalent Inc News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,450.90 | 64.30 | -0.76% |
CAC 40 | 7,236.85 | 9.87 | 0.14% |
DAX 40 | 19,066.63 | 32.99 | 0.17% |
Dow JONES (US) | 43,910.98 | 382.15 | -0.86% |
FTSE 100 | 8,031.83 | 6.06 | 0.08% |
HKSE | 19,823.45 | 23.43 | -0.12% |
NASDAQ | 19,281.40 | 17.36 | -0.09% |
Nikkei 225 | 38,721.66 | 654.43 | -1.66% |
NZX 50 Index | 12,674.49 | 74.87 | -0.59% |
S&P 500 | 5,983.99 | 17.36 | -0.29% |
S&P/ASX 200 | 8,193.40 | 62.20 | -0.75% |
SSE Composite Index | 3,439.28 | 17.31 | 0.51% |